$RELX

RELX: Deutsche Bank reaffirms its Buy rating

Deutsche Bank analyst Steve Liechti reaffirmed a Buy rating on RELX PLC and adjusted the target price from 3,050 to 3,100 GBX, according to MarketScreener. The article also notes UBS previously reiterated a Buy rating. RELX is described as an information and analytics provider across Risk & Business Analytics, Scientific, Technical & Medical, Legal, and Exhibitions.

Original reporting
Published Jul 24, 2026, 1:22 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 24, 2026, 3:24 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefFinancial news
Primary signal
$RELX
Bullish
medium confidence
Mentioned
$RELX
Relevance
4/10
alphai data visualization · based on marketscreener.com
Decision brief

The 30-second read

$RELXBullishLow
01

Why it matters

For trading, the only actionable element is the modest target change; without new company fundamentals, it is unlikely to drive a sustained repricing.

02

Market read

A modest price-target increase on a Buy reaffirmation can support sentiment, but the article does not introduce new fundamentals.

03

What to watch

The piece lacks details on valuation drivers, earnings revisions, or updated fundamentals, so traders should treat it as sentiment rather than a catalyst.

Relevance 4/10Novelty 4/10Timing: published intraday, before the next scheduled company event (no earnings date provided)

Background

The article is a sell-side note recap stating Deutsche Bank maintains a Buy rating on RELX and adjusts its price target slightly upward.

Company-level read

Ticker impact

$RELXBullishMedium confidence
Context

Deutsche Bank analyst Steve Liechti reaffirms a Buy on RELX and slightly raises the target from 3050 to 3100 GBX.

Expected impact

Limited near-term impact; any move is likely to fade unless other analysts follow with similar target changes.

Evidence & confidence

The article provides an analyst rating and target adjustment, with no new earnings, guidance, or company-specific operational update.

Market effects

Minimal sector read-through; this is a single-name rating reaffirmation without new sector data.

No specific regional catalyst beyond UK-listed RELX coverage.

Low; no global macro or cross-asset linkage beyond general analyst sentiment.

Counterpoint

A target tweak from 3050 to 3100 GBX may be too small to matter, especially if the stock has already priced in prior optimism.

Key entities

  • RELX

    Global information and analytics provider; subject of the Deutsche Bank Buy reaffirmation and target adjustment.

  • Deutsche Bank

    Reiterated Buy rating and raised target from 3050 to 3100 GBX in the note described.

  • Steve Liechti

    Deutsche Bank analyst who reaffirmed the Buy rating on RELX.

Related articles

$RELXMed

Relx H1 Earnings Call Highlights

RELX (RELX) reported H1 earnings call highlights, citing growth across Risk, STM, Legal, and Exhibitions. Risk and Insurance benefited from financial crime compliance and digital fraud solutions. STM revenue rose 6% and underlying adjusted operating profit 8%. Legal posted 10% underlying revenue growth and 13% profit growth, driven by Lexis+ with Protégé. Management reiterated full-year growth expectations and said AI token costs are under 1% of costs.

$RELXMed

RELX rises as AI helps with new products and costs

RELX PLC shares rose 1.5% to 2,491p after the FTSE 100 group reported higher first-half revenue and profit. Underlying revenue grew 7% and adjusted operating profit rose 9% to £1.7 billion, with margins improving to 35.5%. The board lifted the interim dividend 7% to 20.9p and said it expects strong full-year growth.

$RELXMed

Why is Relx stock climbing today? By Investing.com

Relx shares rose about 2% in pre-open trading after the company reported H1 2026 interim results. According to Relx, underlying revenue grew 7% to £4,871m and adjusted operating profit rose 9% to £1,727m. Adjusted EPS increased 11% at constant currency, with Legal leading. Relx reaffirmed full-year outlook and said AI-enabled tools supported growth.

$BPMedAI 8/10

FTSE 100 up despite Asia-focused financials falls

The FTSE 100 rose 0.3% to 10,360.32 as oil weakness weighed on majors less than expected; Brent fell to $94.88/bbl. Asia-focused banks and insurers dropped after a report said mainland residents face tighter limits opening offshore accounts in Hong Kong. Prudential fell 7.2%, HSBC 2.2%, Standard Chartered 3.2%. Broadcom sank 14% despite record results.